CORESTA Meeting, Smoke Science/Product Technology, 2023, Cancun, NAM 06
COPD AOP-II: In vitro assessment of mucus hypersecretion with quantitative AOP modeling
Scientific Product Assessment Center, Japan Tobacco Inc., Yokohama, Kanagawa, Japan
The Adverse Outcome Pathway (AOP) framework is a valuable tool for understanding the mode of action of a stressor. While traditionally used to supplement chemical risk assessment, this concept could also be useful in disease-related toxicological...